drugset / Trial / NCT01383330
A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition
RandomizedParallel-groupOpen-label
Summary
The purpose of this study is to evaluate pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in healthy male volunteers under fed condition.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DW-ES(A) | Unknown | 625 mg | — |
| Comparator | DW-ES(B) | Unknown | 625 mg | — |
| Subject | Megestrol Acetate | Other / unclassified | 800 mg | — |
Indications
No indication recorded.